<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04899986</url>
  </required_header>
  <id_info>
    <org_study_id>2021-PBIMPLANT</org_study_id>
    <nct_id>NCT04899986</nct_id>
  </id_info>
  <brief_title>Chlorhexidine Gel and Peribioma Periogel Use in Peri-implant Mucositis Sites: a Split-mouth Randomized Clinical Trial.</brief_title>
  <official_title>Clinical Comparison Between Chlorhexidine Gel and Peribioma Periogel in Patients With Peri-implant Mucositis: a Split-mouth Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the efficacy of non-surgical periodontal therapy with&#xD;
      supportive home oral care for the treatment of peri-implant mucositis.&#xD;
&#xD;
      Patients with bilateral implants with peri-implant mucositis will undergo professional dental&#xD;
      hygiene with ultrasonic handpiece and manual scaler, followed by the application of glycine&#xD;
      Airflow powders. Then, patients will be randomly divided into two groups: the Trial Group&#xD;
      will undergo a split-mouth application of chlorhexidine gel 1% for quadrants 1 and 4 and of&#xD;
      Biorepair Periogel 0.12% for quadrants 2 and 3, with one daily home application for the&#xD;
      following 15 days after the visits and the use of Biorepair Parodontogel toothpaste; the&#xD;
      control Group will not use any gels.&#xD;
&#xD;
      The improvement of peri-implant mucositis will be evaluated between the two groups and&#xD;
      differences between the two gels will be assessed, if present.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the efficacy of non-surgical periodontal therapy with&#xD;
      supportive home oral care for the treatment of peri-implant mucositis.&#xD;
&#xD;
      Patients with bilateral implants with peri-implant mucositis will undergo professional dental&#xD;
      hygiene with ultrasonic handpiece and manual scaler, followed by the application of glycine&#xD;
      Airflow powders. Then, patients will be randomly divided into two groups:&#xD;
&#xD;
        -  Trial Group: split-mouth application of chlorhexidine gel 1% for quadrants 1 and 4 and&#xD;
           of Biorepair Periogel 0.12% for quadrants 2 and 3. Home oral care will be continued with&#xD;
           1 application per day of the two gels for the following 15 days after the visits for the&#xD;
           same quadrants, and the use of Biorepair Parodontogel Toothpaste.&#xD;
&#xD;
        -  Control Group: no application neither of chlorhexidine gel nor of Biorepair Periogel.&#xD;
&#xD;
      The improvement of peri-implant mucositis will be evaluated between the two groups and&#xD;
      differences between the two gels will be assessed, if present, evaluating periodontal indices&#xD;
      at the baseline, after three months and after six months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in BOP - Bleeding On Probing</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Dichotomous scoring (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in GBI - Gingival Bleeding Index (percentage)</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 6 sites.&#xD;
The number of bleeding sites is divided per the total number of probed sites; the ratio is multiplied X 100.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in suppuration</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Dichotomous scoring (yes/no)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in marginal mucosa condition</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Scoring criteria:&#xD;
0: normal mucosa&#xD;
1: minimal inflammation with color change and minor edema&#xD;
2: moderate inflammation with redness, edema and glazing&#xD;
3: severe inflammation with redness, edema, ulceration and spontaneous bleeding without probing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in mucosal margin</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Dichotomous scoring (migrated/non migrated)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probing Pocket Depth</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in PI - Plaque Index (percentage)</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Evaluation of the presence of plaque on the 4 surfaces of teeth on the total amount of dental surfaces.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in BS - Bleeding Score</measure>
    <time_frame>Baseline, 1, 3 and 6 months.</time_frame>
    <description>Scoring criteria:&#xD;
0: no bleeding&#xD;
1: isolated visible spots&#xD;
2: blood forms a confluent red line on mucosal margin&#xD;
3: heavy or profuse bleeding</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Peri-implant Mucositis</condition>
  <arm_group>
    <arm_group_label>Trial Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients from this group will use chlorhexidine Biorepair gel and toothpaste for home oral care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients from this group will not use chlorhexidine and Biorepair gels and toothpastes, but will perform home oral care with standard toothpastes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chlorhexidine and Biorepair gel and toothpaste application</intervention_name>
    <description>Split-mouth application of chlorhexidine gel 1% (quadrants 1 and 4) and Biorepair Periogel (quadrants 2 and 3) after professional dental hygiene. Home oral care will be continued with chlorhexidine 0,12% gel and Biorepair Periogel in the same quadrants, for the following 15 days from the visits, together with the use of Biorepair Parodontogel toothpaste.</description>
    <arm_group_label>Trial Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard oral hygiene</intervention_name>
    <description>Use of standard toothpastes for home oral hygiene.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (18-70 years)&#xD;
&#xD;
          -  Bilateral presence of peri-implant mucositis&#xD;
&#xD;
          -  Patients with high compliance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with cardiac pacemaker&#xD;
&#xD;
          -  Patients suffering from psychological, neurological or psychiatric disorders&#xD;
&#xD;
          -  Patients suffering from systemic, metabolic or autoimmune diseases&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Scribante, DDS, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pavia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia</name>
      <address>
        <city>Pavia</city>
        <state>Lombardy</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 19, 2021</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Andrea Scribante</investigator_full_name>
    <investigator_title>Research Resident, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>non-surgical periodontal therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be available upon motivated request to Principal Investigator</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

